![[Free Webinar] Guide to Securing Your Entire Identity Lifecycle Against AI-Powered Threats](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjqbZf4bsDp6ei3fmQ8swm7GB5XoRrhZSFE7ZNhRLFO49KlmdgpIDCZWMSv7rydpEShIrNb9crnH5p6mFZbURzO5HC9I4RlzJazBBw5aHOTmI38sqiZIWPldRqut4bTgegipjOk5VgktVOwCKF_ncLeBX-pMTO_GMVMfbzZbf8eAj21V04y_NiOaSApGkM/s1600/webinar-play.jpg?#)
Why GeneDx Holdings Stock Is Plunging Today
Shares of GeneDx Holdings (NASDAQ: WGS) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. The steep decline came after the genetic diagnostics company announced its 2025 first-quarter earnings before the market opened.GeneDx reported Q1 revenue of $87.1 million, up 42% year over year. This result was well above the consensus Wall Street forecast of $79.5 million. What about GeneDx's bottom line? The company posted a Q1 net loss of $6.5 million based on generally accepted accounting principles (GAAP). However, its adjusted net earnings for the quarter were $7.7 million, or $0.27 per share. The average analysts' estimate projected adjusted earnings per share of $0.09. Continue reading
Shares of GeneDx Holdings (NASDAQ: WGS) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. The steep decline came after the genetic diagnostics company announced its 2025 first-quarter earnings before the market opened.
GeneDx reported Q1 revenue of $87.1 million, up 42% year over year. This result was well above the consensus Wall Street forecast of $79.5 million.
What about GeneDx's bottom line? The company posted a Q1 net loss of $6.5 million based on generally accepted accounting principles (GAAP). However, its adjusted net earnings for the quarter were $7.7 million, or $0.27 per share. The average analysts' estimate projected adjusted earnings per share of $0.09.
